While CSF3R mutations/variants are mainly associated with myeloid diseases, they have also been identified particularly in B-cell acute lymphoblastic leukemia (B-ALL) and multiple myeloma (MM), most likely a consequence of CSF3R expression in early hematopoietic progenitors. Here, CSF3R is linked to AL amyloidosis.